PARIS, July 29 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) raised its earnings growth goal for the year and outlined new cost savings to help it cope with the effect on profit of patent expiries on a number of its top drugs.
PARIS, July 29 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) raised its earnings growth goal for the year and outlined new cost savings to help it cope with the effect on profit of patent expiries on a number of its top drugs.
